— Know what they know.
Not Investment Advice

RAPH OTC

Raphael Pharmaceutical Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +536.4% 3Y: +35.9%
$1.40
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 43 · $28.2M mcap · 12M float · 0.0013% daily turnover · Short 88% of daily vol

Balance Sheet Trends

Total Assets
$27K -88.7% ▼
3Y CAGR: -60.0%
Total Liabilities
$769K +482.6% ▲
3Y CAGR: +37.8%
Shareholders Equity
-$742K -793.5% ▼
Cash & Investments
$19K -91.7% ▼
3Y CAGR: -50.1%
Total Debt
$41K +0.0% ▲
Net Debt
$22K +109.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024
— Assets —
Cash$153K$288K$230K$19K
Short-Term Investments$0$0$0$0
Cash & ST Investments$153K$288K$230K$19K
Net Receivables$92K$38K$7K$2K
Inventory$0$0$0$0
Other Current Assets$0$0$0$0
Total Current Assets$422K$331K$237K$25K
Property, Plant & Equip.$0$2K$2K$2K
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Other Non-Current Assets$0$0$0$0
Total Non-Current Assets$0$2K$2K$2K
Total Assets$422K$333K$239K$27K
— Liabilities —
Accounts Payable$107K$72K$69K$125K
Short-Term Debt$0$0$0$41K
Deferred Revenue$0$0$0$0
Other Current Liabilities$0$0$0$0
Total Current Liabilities$294K$227K$132K$769K
Long-Term Debt$0$0$0$0
Other Non-Current Liab.$0$0$0$0
Total Non-Current Liabilities$0$0$0$0
Total Liabilities$294K$227K$132K$769K
— Equity —
Common Stock$130K$157K$185K$187K
Retained Earnings-$3M-$6M-$7M-$9M
Accumulated OCI$0$0$0$0
Total Stockholders Equity$128K$106K$107K-$742K
Total Liabilities & Equity$422K$333K$239K$27K
— Key Metrics —
Total Debt$0$0$0$41K
Net Debt-$153K-$288K-$230K$22K
Total Investments$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms